Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2003-2-24
pubmed:abstractText
The role of p53 in modulating apoptosis has suggested that it may affect efficacy of anticancer agents. We prospectively evaluated p53 alterations in 73 patients with locally advanced breast cancer (IIIB) submitted to neoadjuvant chemotherapy.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0923-7534
pubmed:author
pubmed:issnType
Print
pubmed:volume
14
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
428-32
pubmed:dateRevised
2006-4-24
pubmed:meshHeading
pubmed-meshheading:12598349-Adult, pubmed-meshheading:12598349-Aged, pubmed-meshheading:12598349-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:12598349-Apoptosis, pubmed-meshheading:12598349-Breast Neoplasms, pubmed-meshheading:12598349-Doxorubicin, pubmed-meshheading:12598349-Female, pubmed-meshheading:12598349-Gene Expression Regulation, Neoplastic, pubmed-meshheading:12598349-Genes, p53, pubmed-meshheading:12598349-Humans, pubmed-meshheading:12598349-Immunohistochemistry, pubmed-meshheading:12598349-Middle Aged, pubmed-meshheading:12598349-Neoadjuvant Therapy, pubmed-meshheading:12598349-Paclitaxel, pubmed-meshheading:12598349-Predictive Value of Tests, pubmed-meshheading:12598349-Prospective Studies, pubmed-meshheading:12598349-Treatment Outcome, pubmed-meshheading:12598349-Tumor Markers, Biological, pubmed-meshheading:12598349-Tumor Suppressor Protein p53
pubmed:year
2003
pubmed:articleTitle
Correlation of p53 status with outcome of neoadjuvant chemotherapy using paclitaxel and doxorubicin in stage IIIB breast cancer.
pubmed:affiliation
Department of Medical Oncology, Hospital do Câncer de São Paulo, São Paulo, Brazil. aanelli@node1.com.br
pubmed:publicationType
Journal Article, Clinical Trial